Forma Therapeutics to Participate in Upcoming Investor Conferences
17 May 2021 - 9:05PM
Business Wire
Forma Therapeutics Holdings, Inc. (Nasdaq: FMTX), a
clinical-stage biopharmaceutical company focused on rare
hematologic diseases and cancers, today announced that company
management will participate in two upcoming investor
conferences:
- The Oppenheimer Rare & Orphan Disease Summit taking place
Friday, May 21, 2021. Forma’s pre-recorded presentation will be
available on May 21 at 8:00 a.m. EDT.
- The Jefferies Virtual Healthcare Conference taking place June
1-4, 2021. Forma will present on June 2 at 11 a.m. EDT.
Webcasts/audio recordings of the conference presentations will
be available in the “News & Investors” section of Forma’s
website at www.formatherapeutics.com.
About Forma Therapeutics
Forma Therapeutics is a clinical-stage biopharmaceutical company
focused on the research, development and commercialization of novel
therapeutics to transform the lives of patients with rare
hematologic diseases and cancers. Our R&D engine combines deep
biology insight, chemistry expertise and clinical development
capabilities to create drug candidates with differentiated
mechanisms of action focused on indications with high unmet need.
Our work has generated a broad proprietary portfolio of programs
with the potential to provide profound patient benefit. For more
information, please visit www.FormaTherapeutics.com or follow us on
Twitter @FORMAInc and LinkedIn.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210517005098/en/
Investors: Mario Corso, +1 781-366-5726 Forma
Therapeutics, Inc. mcorso@formatherapeutics.com
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Jul 2024 to Aug 2024
Forma Therapeutics (NASDAQ:FMTX)
Historical Stock Chart
From Aug 2023 to Aug 2024
Real-Time news about Forma Therapeutics Holdings Inc (NASDAQ): 0 recent articles
More Forma Therapeutics Holdings Inc News Articles